NCT06943885Recruiting
Comparison of 5G-Mobile Stroke Unit With Standard EMS for Acute Ischemic Stroke
Comparison of 5G Mobile Stroke Unit to Standard Management by Emergency Medical Services For Acute Ischemic Stroke Treatment：A Multicenter, Prospective, Open-label, Blinded Endpoint , Week-wise Randomized, Controlled Trial
Source: ClinicalTrials.gov · Last updated 14 May 2025 · Not updated for over 12 months - ask the site whether it is still open
Brief summary (registry, in English)
While Mobile Stroke Units (MSUs) are considered as a relatively new model for acute stroke treatment, 5G Mobile Stroke Units (5G MSUs) have already come into service for stroke treatment in some parts of China. Since limited evidence has been found to suggest their advantages over conventional Emergency Medical Services (EMS), well-conducted clinical studies are required to further assess their effectiveness and safety. This study aims to evaluate whether 5G MSUs outperform standard management (SM) by EMS in terms of functional outcomes of acute ischemic stroke (AIS) patients within 4.5 hours after symptom onset in urban and rural areas of China.
- Status (registry)
- Recruiting
- Study type
- Interventional
- Enrollment
- 952 (estimated)
- First submitted
- 17 Apr 2025
- Start date
- 25 Apr 2025
- Primary completion date
- Oct 2028
- Lead sponsor
- Beijing Emergency Medical Center
- Diseases
- Stroke
- NCT number
- NCT06943885
What you commit to
- Study type: Interventional
- Planned participants: 952
- From 25 Apr 2025 to the primary completion date, Oct 2028
- 1 site in 1 country
- Visits and tests: ask the trial team, the registry does not list them
Built from the registry fields of ClinicalTrials.gov. It describes the study, not your situation.
Who cannot take part
Copied verbatim from ClinicalTrials.gov and grouped by topic. Only the trial team decides who can take part.
Prior treatment
- Participation in other interventional randomized clinical trials within 3 months before enrollment.
Other illness
- Malignant or other severe primary disease with life expectancy \<1 year.
Who the study is looking for
- History and physical/neurological examination consistent with acute stroke.
- Age≥18.
- Last seen normal within 4hr 30 min of symptom onset.
- Pre-stroke modified Rankin scale ≤3（Being able to ambulate）.
- No rt-PA/TNK exclusions per guidelines, prior to CT scan or baseline labs.
- Informed consent obtained from patient (if competent) or legal representative.
Age in the registry: 18 years to - · Sex: All · Does not accept healthy volunteers
Sites (1)
Sites in registry order. Pick your city on the disease page to sort them by distance.
| Site | City | Country | Site status |
|---|---|---|---|
| Beijing Emergency Medical Center Coordinator of this site? Confirm its status | Beijing | China | Recruiting |
This page is information, not medical advice. Discuss any trial with your doctor.